Quantum Dots (QD) Market Revenue Will Reach $5.04 Billion, Globally, by 2020

According to a new research report published by Allied Market Research titled "Quantum Dot (QD) Market - Global Analysis, Growth, Trends, Opportunities, Size, Share and Forecast through 2020," the global quantum dots (QD) market accrued revenue of $316 million in 2013 and it is expected to grow to $5,040 million by 2020 at a CAGR of 29.9% during 2014-2020. However, the volume consumption will grow a much faster rate of 116.5% during the same period to reach 72 ton in 2020. The high volume-value growth gap will be resultant of faster price erosion during the analysis period. The decline in prices can be attributed to the refinement of manufacturing technologies & mass production processes and high volume demand.

                      

Quantum dot (QD) market global analysis, growth, trends, opportunities, size, share and forecast through 2020 from Allied Market Research

The key drivers for the growth of the QD market are efficient conversion of solar energy into power, rising use volume driven display devices and utility in multiple applications. Additionally, this technology is more efficient than conventional technologies. From the competitive scenario, display and lighting equipment manufacturers are eager to bring out QD based products, which is currently the prime factor for quantum dot market growth. "The QD display market is set to grow exponentially as many companies such as Sony Corp., LG Display etc. are getting into alliance with QD technology providers to commercialize QD displays, especially TV sets," note analysts Shreyas Naidu and Priyanka Gotsurve. "The QD technology enhances the color display by at least 50% and it is also an energy efficient technology," analysts added.

To read more, get a sample copy or to purchase the complete report, visit: http://www.alliedmarketresearch.com/quantum-dots-market

However, some of factors such as high cost of technology and slow adoption due to extended research are currently serving as the restraints for the market growth. Although, mass manufacturing and bulk purchasing will quickly negate the cost constraints. The further penetration of the technology in newer applications such as security & defense, food, and packaging will provide the essential future growth thrust to the market.  Furthermore, future use of newer and cost effective materials will provide the QD market an added competitive edge over other competitive materials such as organic dyes.

To request or get free sample visit here:

https://www.alliedmarketresearch.com/request-free-sample/141

Among geographic markets, North America has the highest revenue share due to early adoption. The region is expected to grow consistently and attain revenue of $1.92 billion by 2020. However, Asia-Pacific is expected to have the highest CAGR of 30.4% for the analysis period 2013-2020.

Enzymes Market is Expected to Reach $5.4 Billion, Worldwide, by 2020

According to a new report by Allied Market Research titled, "World Enzymes Market -Opportunity and Forecast, 2014-2020", world enzymes market is expected to register a CAGR of 7.8% during 2015-2020. The household care segment holds about 1/3^rd of the overall market share in 2014, due to large consumption of varied enzymes in detergents industry.

                         

Presently, enzymes are witnessing high demand in various industries such as biofuels, food & beverages and detergents. The growing popularity of enzymes for production of renewable fuels such as biodiesel, preference of enzymes for manufacturing mild detergents and rising adoption of enzymes in pharmaceutical formulations are the key factors fueling the market growth. In addition, growing use of feed enzymes in animal nutrition would further boost the market growth. However, high sensitivity of enzymes to temperature and pH and risk of contamination would limit the overall market growth.

To know more about the report, visit the website at https://www.alliedmarketresearch.com/enzymes-market

Carbohydrases enzymes segment held a dominant position in 2014 and would continue to lead over the forecast period. This is due to its wide range of applications in detergents and food & beverages industry for the degradation of carbohydrate rich compounds such as starch. However, polymerases & nucleases segment is projected to be the fastest growing segment owing to its growing utilization in biotechnology and pharmaceutical research. Based on reaction, Hydrolases enzyme segment dominated the market with around 77.9% market share in 2014. This is due to the large scale use of hydrolytic enzymes for the hydrolysis of carbohydrates and proteins. Based on source, microorganism derived enzymes was the leading revenue generating segment (due to its feasibility for large scale production and wide range of applications) in 2014, accounting for around 3/5^th of the overall market.

Key findings of the study: 

• Pharma & biotech application is projected to deliver fastest growth during the forecast period
• Plant derived enzymes segment would witness fastest adoption during the forecast period
• The Asia Pacific would exhibit fastest growth during the forecast period

North America dominated the global enzymes market in 2014, due to established industrial manufacturing base and large adoption of advanced enzymes such as immobilized enzymes in this region. Key players operating in this market are continuously focusing on strategies such as acquisition and product launch to increase their manufacturing capacity, expand their market presence and gain additional market share. Many companies are actively developing advanced enzymes such as immobilized enzymes to maintain the standards of end products. Key companies profiled in the report are Novozymes (Latest News), DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix Inc., and Codexis Inc.

Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Int'l: +1 (503) 505-6949
Toll Free: + 1-800-792-5285 (U.S. & Canada)
E-mail: sales@alliedmarketresearch.com

mHealth Market to Grow at an Impressive CAGR of 33.5% During 2015 - 2020

A new report by Allied Market Research, titled, "Global mHealth Market (Device, Service, Application, Stakeholders and Geography) - Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2014-2020", stated that the global mHealth market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. Blood pressure monitors hold the largest share in the global mHealth device market followed by blood glucose monitors and cardiac monitors. Geographically,North America will continue to retain its leading position in the overall mHealth market throughout the analysis period.

                    

mHealth Market (Devices, Services, Application, Stakeholders and Geography) - Trends and Forecast, 2014 - 2020 from Allied Market Research

Mobile health provides health service and information through mobile communication devices to address the health priorities and concerns. The advanced mobile and wireless technologies have transformed the face of healthcare services across the globe and are rendering the growth of mHealth market. Moreover, the continued growth in coverage of mobile cellular networks, rapid advances in mobile technologies & applications, increasing lifestyle diseases and growing awareness among patient population in emerging economies, are some of the key factors fostering the growth of global mHealth market. On contrary, the lower accuracy of devices, technology infancy in middle and lower income economies, weak reimbursement coverage, uncertainty in government regulations in certain regions, and low adoption among ageing population is hampering the market growth to certain extent.

To request more information about the report, visit the website at https://www.alliedmarketresearch.com/mhealth-2015-market

The major chunk of mHealth devices market - i.e. ~71% - is collectively commanded by BP monitors, blood glucose monitors and cardiac monitors. The large share of these monitors can be attributed to increased affordability of mobile compatible devices, integration of innovative technologies in monitoring devices and the increasing lifestyle disease such as diabetes, stroke, COPD, ischemic heart to name a few. Within mHealth services, diagnostic, monitoring and treatment services collectively hold about 74% of the market. The rapid growth of mHealth services market is attributed to rising government initiatives, increasing mHealth awareness programs in underdeveloped regions etc.

View the mHealth market forecast 2012 - 2020 at https://www.alliedmarketresearch.com/mobile-health-market

Key finding of the study 

• Blood glucose meters is projected to be the fastest growing segment in global mHealth devices market registering a CAGR of 41% during the forecast period
• United States continues to be the leading market in the North America mHealth market throughout the forecast period
• Asia-Pacific is projected to be the fastest growing mHealth market registering a CAGR of 35.9% during 2015-2020
• United Kingdome, France and Germany collectively accounts to 45% share in the Europe mHealth device market in 2014
• Cardiovascular and diabetes mHelath application market remains the lucrative market segment for manufacturers

Geographically, North America and Europe constitute the two largest markets for mHealth and collectively accounted for 67% of the market revenue in 2014. They are expected to continue its hold on the global market throughout the forecast period. Early adoption of innovative technology, large patient population and high capacity to pay for services are some of the key factors responsible for the growth of mHealth market in these regions. However, the market outlook across developing economies is looking favorable and strong owing to the increasing awareness of chronic diseases, favorable government regulations and increased healthcare expenditure. Philips healthcare, Bayer Healthcare and Sanofi are some of the key companies enjoying a strong foothold in global mHealth market, especially in Asian countries. Key players profiled in this report include - Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Cardionet Inc., Masimo Corporation, Sanofi, Boston Scientific, AT&T Inc., and Johnson & Johnson.

Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Int'l: +1 (503) 505-6949
Toll Free: + 1-800-792-5285 (U.S. & Canada)
E-mail: sales@alliedmarketresearch.com

Health Experts Call For Funds To Boost Ebola Vaccine Shots

Last year, approximately 27,000 people were infected by the Ebola virus in West Africa. Several sources reveal that over 11,000 of them succumbed to the outbreak in 2014. The entire medical fraternity believes that effective Ebola vaccines would have saved many lives. However, the fact that the entire world now depends upon latest drugs or vaccine for the virus too cannot be ignored. This outbreak has affected mostly poor nations like Liberia, Leone and more. It was only after a public alarm; health officials from regions like Europe as well as United States paid a visit to West Africa. The sudden outbreak also persuaded scientists to develop and test potential vaccine candidates that had been awaiting consent for years. Several clinical trials in regions including Guinea too show that the latest inventions have proved fruitful.

 In addition, close to $ 8 billion was spent in Guinea, Liberia and Sierra Leone for the development of Ebola drugs and treatment reported ‘NY Times ‘.  The same source revealed that getting a vaccine costs anywhere between $500 million as well as $1 billion. These funds help several drug manufacturers or biotechnology firms and scientists that are working hard to produce vaccines but are deprived of resources to manufacture them or seek an approval. Moreover, with the ‘World Health Organization’ supporting clinical trials of the vaccine in areas including Guinea has acted as a boon for fund raising and has attracted contributions from several private companies and drug makers for new virus vaccine.

In July 2015, health experts from across the global seconded the need for creating a $2 billion Ebola virus vaccine production fund to boost new shots. Commenting on this the Welcome Trust’s director, Jeremy Farrar said "We can no longer sit back and ignore the chronic lack of progress in developing new vaccines, and improving existing ones." Jeremy was of the co – writers responsible for creating the fund. Allied Market Research has added a report titled “Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020.” As per the report the vaccine manufacturing in regions such as Asia – Pacific, LAMEA, Europe and North America would observe tremendous growth.

Technology Trends Drives The Capsule Endoscopy System In 2015

Over the past few years medical sensors have become smaller. The MEMS (or Microelectrical-mechanical systems) have been popular in medical equipment, from stents to chemosensor. Even the capsule endoscopy systems comes with a miniature camera as well as radio technologies. These systems captures the images of human digestive tract from the inside. Latest discoveries in the data analytics, material science and equipment engineering collectively promise a much smaller and modish sensor. 

The recent development in miniaturization assures biocompatibility. Medical experts believe that the smaller the system, the less likely it would interfere with the immune mechanism. This is true for capsule endoscopy used to take images of the entire gastrointestinal tract. PillCam® SB launched by Covidien boasts of vitamin –sized, wireless pill design that can improve the diagnosis for small bowel diseases. Recently, a Vanderbilt University engineer, Pietro Valdastri received $1.5 million as grant to continue the development of his a unique magnetic capsule for patients with IBD.  

Besides this, miniaturization when combined with the latest electrochemical as well as optical techniques boosts specificity & sensitivity for several medical conditions or uses. For example, scientists indicate that when size of the capsule endoscopy system is reduced it allows medical professional pick up the elements on the device. The Qatar International Medical Congress held between May 26 – 28, 2015 also included video capsule endoscopy as well as many sensitive, yet important, next generation concepts on palliative care.

Apart from this, boom in data analytics have also observed some of the greatest advancements in the medical sensors industry. Medical experts now combine the sensor data with improved analytics as well as machine learning techniques to diagnose diseases accurately. Allied Market Research has published a report titled “World Capsule Endoscopy System - Market Opportunities and Forecast, 2014 – 2020.” As per the report the capsule endoscopy system would register a CAGR of 14.8 percent during the forecast period of 2014 to 2020 worldwide. The aforementioned report also uncovers there would a significant development of the capsule endoscopy system in regions such as North America, LAMEA, Asia Pacific and Europe.

Specialty enzymes find immense application in therapeutics

Enzymes are proteins naturally produced by living organisms that stimulate and speed up bio-chemical reactions. These prove beneficial in building new cells, repairing damaged ones in the blood and tissues of organisms. As these are multifunctional and have high specificity, they find widespread applications in pharmaceutical industries, in diagnosing chronic diseases and in the treatment of various ailments including cancer, cardiovascular diseases and more. Several Industrial and household catalysis depends on the activity of enzymes as they lower activation energy and improve manufacturing efficiencies. Besides, they are cost effective and act as eco-friendly catalysts in various industrial, environmental and consumer products.

Specialty enzymes are proteins that are used in pharma, biotech & diagnostics, and act as biocatalysts in reaction, accelerating the pace of reactions thus acting as a cost-effective and eco-friendly entity in industrial and environmental products. Specialty enzymes find immense applications in areas such as molecular biology and creating molecules that have effective therapeutic uses. These enzymes are recommended by doctors to control incidences of digestive disorders, recent clinical trials point towards reliable evidences in being used as treatment therapy for diseases like cancer. Administered individually or with other treatments specialty enzymes such as prolactazyme, collagenase treats skin ulcer. Enzymes like asparaginase and streptokinase are used to treat various diseases. These enzymes are used in small amounts in therapeutics so that they do not cause any side effect. Furthermore, they must be highly purified and have a high degree of specificity. For instance alkaline phosphatase and peroxides are used in immunoassays.

Recently, researchers at the Centenary Institute in Sydney have uncovered new information about an enzyme called DPP9. They believe DPP9 is a potential therapeutic target and limits the growth of cancerous cells in liver. Currently, the molecule is highly powerful and needs to be externally regulated. Researches are also trying to ascertain how the cells of the body can achieve this naturally. Professor Mark Gorrell, who is behind the discovery of DPP9, is currently researching on the functionalities of the enzyme. There are other such endeavors undertaken by the research departments of prominent pharma industries and market analysts are observant of the growth dynamics of global specialty enzymes. Recently, a report by Allied Market Research titled “World Specialty Enzymes (Pharmaceuticals, Biotechnology R&D, Diagnostics)”. As per the report, specialty enzymes market for biotechnology research, pharmaceuticals and diagnostics was valued at $561.9 million in the year 2014 and would generate a revenue of $947.5 million by the end of 2020, growing at 9.4% CAGR amid the period 2015 - 2020.

Biosimilar Drugs Promises Cost Effective Treatment Even For Deadly Diseases

Follow- on biologics (FOBs) is a biological, inventor developed product that has greater similarity to biological products that has been already approved. Both approved biological medicines and FOBs have no clinical difference when it comes to the safety as well as potency of the products. The application of FOBs also popular as biosimilars in blood disorders, Oncology diseases, deficiencies in growth hormones plus may others, exhibit the greatest market potential as a result of dynamic patent scenario. 

Wider choice for biologic oncology treatment have now invaded markets including United States. The arrival of biologic for cancer treatment would help drive low cost for many of the highly –priced products in patient care. Treatments that worked as restraint for cancer’s biological substructure have undergone drastic change for some cancer types. The arrival of biosimilar now accounts for approximately ½ cancer medicine spending up from nearly 11 percent 10 years back reported IMS Institute. Recently, Hetero pharmaceuticals introduced their biosimilar medicine Rituximab in India under MABALL found effective in treating blood cancer.

In another incident the FDA recognised the first FOBs in the US. The regulatory body confirmed that the medicine Zarxio can now be used for various chemotherapy treatments. This drug aids in the production of white bloods cells in a patient’s body. Besides this, the drug is a generic make of the Neupogen. Apart from this absence of cost effective drug in the GHD treatment market also signifies great opportunity, because the latest biologics popular as biobetters is costly.

Today, FOBs are being used to a greater extent in NHS. Similarly, NICE also comprises of biosimilars in its new technology which is an appraisal on somatropin. Health professionals believe that the biosimilar drugs for hormonal deficiency would be highly accessible and become popular over the next four to five years Biosimilars provide NHS significant cost saving, majorly as they are effective for treating long – term medical conditions.

AlliedMarket Research has published a report titled “World Biosimilars/Follow-on-Biologics - Market Opportunities and Forecast, 2014 – 2020.” As per the report the FOBs industry would register a growth of nearly 49.1 percent during the forecast period 2014 to 2020.

Radial tires has revolutionized the global pneumatic tires industry

The market of tires in general is driven by the large scale manufacture of tires in automotive industry and their large adoption across passenger and industrial vehicles. Tires are highly engineered structural composites which are designed to provide good vehicle control and maneuvering, retreading and traction criteria, along with meeting safety and performance expectations of the customer.

Pneumatic tires are rubber tires filled with compressed air, the other raw materials being carbon black, steel wire, fabric, steel, polyester, nylon, and rayon, fabric cord and wires. The pneumatic tire market is largely driven by a tremendous increase in automobile production globally along with rise in the demand of tires in the replacement market.

The global pneumatic tire market is segmented based on the vehicle type, type of sale, product type and geographical locations. On the basis of type, pneumatic tires market is segmented into radial and cross-ply tires. On the basis of the type of vehicle, the global pneumatic tires market is segmented into two-wheelers, four-wheelers, aircraft, industrial vehicles, agricultural vehicles amongst others. Based on the above type, four wheelers tire segment generates the maximum revenue-generating category. Among four wheelers, pneumatic tires market is gaining prominence in being used in passenger cars, industrial vehicles and their increased adoption in transportation industry.

The advent of radial tires has revolutionized the entire market of pneumatic tires offering high growth momentum to the global pneumatic tires market. The aforementioned segment amount for 68.8% of the total tire market in terms of value in the year 2014, growing at 7.2% CAGR amid the forecast period. Sometimes radials pneumatic tires are constructed with many layers of steel belts in the tread and sidewall which easily repel sharp-cutting objects such as nails and staples. A major German automotive manufacturing company, Continental AG, has recently launched pneumatic radial tire ContiRT20 useful particularly for their larger forklifts. They offer greater resistance to puncture, have increased lateral stability and high retreading potential.

Recently, Allied market Research has published a report titled “World Pneumatic Tire - Market Opportunities and Forecasts, 2014 - 2020”. As mentioned in the report, the global pneumatic tire market is expected to contribute a revenue of $287.5 billion by the end of 2020, growing at a CAGR of 7.0% amid the period of 2015–2020.  Key companies profiled in the report are Continental AG, Michelin, Cooper Tire & Rubber Company, The Goodyear Tire and Rubber, Bridgestone Corporation, Company, Hankook Tire Co. Ltd., Sumitomo Rubber, The Yokohama Rubber Co. Ltd., Industries Ltd., and Kumho Tire USA, Inc, amongst others.

Microwave Oven Maker Focus On Design Flexibility

Worldwide, people are taking to microwave cooking, as they believe it is healthy. To woo customers, microwave brands are now offering customers more than just, traditional cooking, grilling and steaming. Furthermore, with the aim to make these appliances a powerhouse of cooking, manufacturers are considering improvements in their existing freestanding or in –built features. Quick Touch model from Breville is a finest example that offers consumers a user-friendly interface. The brand enables users to adjust power level easily and accordingly to suit a particular food type. Breville’s top –selling make secures approximately 8.7% market value share in, the over $300 price category.

Another microwave manufacturer Panasonic is busy concentrating on the convenience of use, automatic features as well as whip smart technology to help buyers reap optimum benefits from their microwaves.  The new microwave innovation from the company promises multiple cooking techniques such as latest steaming feature for nutritious, delicious food, defrost function and more. Healthy and easy to cook meals also go hand – in – hand for microwaves from Sharp. Besides convenience cooking, the appliance enable easy meal preparation for nutrition – packed food at an affordable price and the trend is significantly visible in the Australia. The latest model from Sharp come with cutting - edge features including Sensor and Flatbed features, which makes the cooking experience easy and simple.

LG Electronics too has paid attention to innovation. The brand intends to introduce easy to clean microwave ovens.  Latest model ‘32-Litre Stainless Steel Convection Oven With Grill’ from the makers come with interior made of stainless steel backed by grease removal coating. The features make cleaning completely fuss-free. The model also boasts of its humidity sensor that instantly identifies vapour and can adjust the power levels as well as meal preparation time during cooking. Allied Market Research has published a report titled “World Microwave Oven Market - Opportunities and Forecasts, 2014 – 2020.” As per the report the microwave oven industry would observe growth in regions such as LAMEA, North America, Europe and Asia –Pacific.

Comfort Is The New Mantra Of Footwear Industry

Footwear’s are inspired by lifestyle! From flamboyantly decorated flip –flops, fabulous high heels to ballet flats footwear, brands are now assuring comfortable fun. Today, local and international manufacturers focus more on insole design, smart leather and custom – manufactured shoe-in-shoe features, dependable and flexible for walking on different surface.

Also, understanding that customers are looking for footwear that offers only pleasure, and no pain brand like ‘Naturalizer’ decided to enter women fashion duty shoe segment to fulfil safety requirements at work. Launched under the name ‘‘Naturalizer@work’, the brand uses patented multi-density foam inserts to ensure more breathability, resilient cushioning, moisture management and more. To carry company’s comfort legacy forward, Naturalizer has paired up with the components company Ortholite. The product would hit the company stores on August 15, 2015 and priced from $99 to $199.

Another, global player in the footwear Converse has finally decided to make the Chunks more comfortable. The new addition is an improved version of the brands ‘Chuck Taylor’ collection – and the key mantra would be comfort. Chuck II would cost buyers approximately $15 more than the existing collection, revealed Bloomberg. For all those who work on their feet all day long RefrigiWear had designed new shoe series including Iron Hiker, Rally Hiker and Rustic Hiker. The series feature cutting –edge VitaComfort™ layer with a 360 degree cushioning along with additional foam padding to ensure great comfort level. The innovative VitaComfort™ layer works as a shock absorber that help users’ lower back pain, foot as well as knee pain.

Other brands making feet happier than ever includes Dr. Scholl’s, Birkenstock, Crocs, Ugg Australia and Keds among many others. Allied Market Research has published a report titled “World Footwear - Market Opportunities and Forecasts, 2014 – 2020.” As per the report the footwear market in LAMEA, North America, Europe and Asia –Pacific would witness a significant growth.

R & D To Boost Innovation In The Packaged Food Segment

Today packaged food brands have become more unequivocal, when it comes to shelf life. Besides this, key market players investing millions in research and development, shows commitment to the segment (processed food market), which strived over a decade amid dynamic buying preferences. Whether it’s about removing artificial flavours or reducing the sodium level in the frozen food, packaged foods are rebooting their chef –inspired food products rather than the diet fare.

To keep pace with emerging trends, Nestle has introduced several changes within its popular frozen range. In June 2015 this global packaged food giant announced plans to do away with artificial flavours. Nestle has invested over $50 million in its R & D center. Other recent product developments include the use of organic ingredients and gluten-free processed foods. Commenting on the advancements, the CEO of Nestle United States, Paul Grimwood said “I’m pleased that Nestle R&D. Solon will enable us to better anticipate and provide consumers with the food choices they deserve and the quality they have come to expect from Nestle.”

Another popular brand, Tyson Foods made public that the company would continue focusing on product innovation. In 2014, the company had acquired the Hillshire Brands. As a result of the investment, the Tyson Foods now manages two invention centers. The CEO and president of Tyson Foods, Donnie Smith in his interview to the media made it clear that the company aims at using all great expertise around discovery and research and development, to grow as they move forward. Now, the Hillshire Brands and Tyson Foods make one company with over $40 billion figure in sales as well as portfolio of famous brands consisting of State Fair, Jimmy Dean, Hillshire Farm plus many others.

Kraft Foods Group, Inc. too experienced a management shake-up in February 2015. Under the leadership of John Cahill, the new CEO company announced two fresh roles. While George Zoghbi then Vice Chairman of operations, research and development and strategy was appointed COO, Chris Khempczinski took over as the Vice President of growth initiatives .Chris is also responsible for the company's international business. Besides this, Kellogg’s had started a new research center in Leuven Bio Incubator in 2013. The company intends to excel in terms of discovery and strengthen its present relationship with Europe market.

According to a report published by “Allied Market Research " titled " World Packaged Food - Market Opportunities and Forecasts, 2014 - 2020 " the packaged food segment globally would witness growth in regions including Europe ,LAMEA and Asia-Pacific.

Towards achieving the goal of “personalized” medical care in CRPC/HRPCA Therapeutics market

Prostate cancer is the most dominant cancer affecting men in the United States and castration-resistant prostate cancer is the most frequently diagnosed cancer in North America. According to an estimate by American Cancer Society, prostate cancer is the fourth most common cause of cancer death overall and estimated to be only third most common cause of cancer death among men. Castration-Resistant Prostate Cancer (CRPC) is defined as the progression of prostate cancer even after administration of androgen deprivation therapy (ADT).

Castration-resistant prostate cancer (CRPC) used synonymously with androgen-independent (AIPC) and hormone-refractory prostate cancer (HRPC) and may consists of one or any combination of a continuous rise in serum levels of prostate-specific antigen (PSA), progression of pre-existing disease, or appearance of new phases of metastases. Recent advances in research technology and high-profile molecular characterization of the disease have led to discovery of new therapies in the CRPC therapeutics market and with an objective to target different pathways. The development of innovative therapies such as chemotherapy coupled with the novel breakthrough treatments will revolutionize patient management strategies in CRPC patients globally, resulting in the tremendous growth of the market. Chemotherapy is emerging as a preferred option of treatment of advanced stages of CRPC in comparison to other hormone therapies, such as abiraterone and enzalutamide, since it is less expensive than the former and also more effective.

 The market would be dominated by the developing regions of Asia-Pacific and third-world countries such as Latin America and Africa. As per a recent report by Allied Market Research titled “World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 – 2020” (CRPC)/HRPCA therapeutics market would reach $9.5 billion by the end of 2020, growing at 9.1% CAGR globally amid the forecast period. With increasing number of clinical trial options for CRPC treatment than before, the market is witnessing development of therapies that target alterations unique to an individual patient's prostate cancer molecular profile at a specific point in time. In recent drug developments brought about by global pharma companies, docetaxel has become a foundation on which researchers add novel agents aimed at increasing efficacy of the therapy treatment for HRPC. In a recent STAMPEDE clinical trial, presented by Dr Nicholas James from the University of Warwick, UK, the findings confirm that the addition of docetaxel to standard hormonal therapy greatly improved chances of overall survival (OS) among men with newly diagnosed advanced prostate cancer.

Efforts are being made by researchers in the more effective characterization of molecular targets and mechanisms that lead to tumour growth in CRPC. As a result, many global pharma companies are investing their resources in the development and field trials of drugs that involve continuous activation of the androgenic receptors (ARs).

Healthcare providers are working on developing management strategies that consist of finding newer ways to increase the survival of men with progressive stages of prostate cancer. These developments are truly making CRPC treatment as an example of personalised medical care. This will offer invaluable help for clinicians to make wiser decisions in treating CRPC. However, achieving the goal of offering personalized medical treatment for this common malignancy will be a daunting task, closely watched by market participants and healthcare providers alike.

Anti –Counterfeiting Technologies Continue Their Fight Against Fake Clothing And Accessories

Today, counterfeit clothing and accessories pose a great problem for buyers, retailers and even the regulatory bodies. Furthermore, commenting on the growing counterfeiting cases worldwide, the South African Clothing and Textile Workers Union’s, senior researcher, Simon Eppel said “It hampers economic growth and job creation and leads to greater income inequality. In this way, fraud also jeopardises the economic and industrial policy initiatives of the state.” According to an article published in the “iOL News “over R3 billion loss was recorded in South Africa alone, due to the fake designer clothing and accessories being brought into the nation. In a similar incident, the “Worcestershire News” in their 6 July 2015 edition reported raids carried out on houses linked to fake designer clothing sales on social media platform like Facebook.

Likewise, the “World Customs Organisation”, indicates that fake clothing’s and accessories have cost fashion brands approximately 400,000 job losses. The aforementioned organization further uncovered that close to £5 billion in proceeds was lost over past 20 years due to counterfeit clothing. In the United Kingdom alone fake designer clothes are believed to cost the country’s economy nearly £1 million in both tax and profits. Moreover, in recent years there has been a significant rise in the counterfeit clothes sold online. So to beat the heat, many new technologies are being implemented that can help brands tackle fake designer clothing and accessories.

In 2014, some chemical engineers at MIT predicted that soon shoppers would be able to identify fake goods themselves. These engineers highlighted that soon smartphones would enable customers to detect brand ID codes using infrared technology.  Similarly, in May 2015 Stora Enso and NXP introduced their smart packaging solution with NFC. Stora Enso integrates a RFID system provided by the NXP Semiconductors with its product packaging solutions. Commenting on their achievement NXP explained “By using NXP RFID technology such as NFC and ultra-high frequency (UHF), Stora Enso smart packages can be easily tracked and traced through the entire supply chain providing full end-to-end transparency.” Besides this, bar codes and upcoming track – and – trace systems like DNATrax would soon be in vogue to ensure safe packaging that prevents copy, promises safety of the packaged clothes and accessories and protects the integrity of the supply chain management.

Considering the recent boom in the global anti-counterfeit clothing and accessories packaging market, a report published by “Allied Market Research “indicates that the aforesaid market would grow by leaps and bounds . According to the report the anti-counterfeit clothing and accessories packaging segment would see a CAGR of 9.9 percent by 2020.

The Therapeutic Market For Anti –Inflammation Expands To Promise Relief

Today, growing concerns over diseases such as arthritis, IBS, respiratory diseases, Psoriasis and more have become the key market drivers for the growth of anti-inflammation therapeutic industry. Furthermore, a report published by “IMS Health “, the total pain management drugs or pharmaceutical industry , in United States alone was valued at $18.2 billion in the year 2012. The existing medications to treat pain, majorly comprises of anti-inflammatory biologics, NSAIDs as well as COX inhibitors. Furthermore, while the NSAIDs are used to treat the mild to moderate inflammation opioids are found useful in treating moderate to severe pain.

A study carried out by “La Merie Publishing”, shows that the total sales of the biologics in figure in 2014 was approximately US$ 141 billion. The same study reveals that the biologic market generated up to US$ 140 in 2013. Similarly, the demand to relief inflammation and pain has gained great momentum with a rise of nearly 12.9 percent for the anti- TNF antibodies, coupled with a hike of 20.1 percent for other anti-pain and inflammatory antibodies. Moreover, over US$ 47 billion in figures was generated by the total of different anti-inflammatory antibodies by the end of 2014. Gustav Ando an analyst in IHS, commenting on the expanding biologics market said: “The industry is becoming increasingly involved in biological drugs. We're seeing a lot of dramatic breakthroughs in the science of biologics."

Apart from this the NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are most commonly used drugs to relief osteoarthritis, which is a most popular form of arthritis as well as mild pain.  The NSAIDs can cost anywhere between $4 to $1,5000 every month. Etoricoxib which is the widely sold NSAIDs and accounted for about 14 percent sales in countries such as Malaysia, Bangladesh and Hong Kong reveals a study conducted by the “William Harvey Research Institute”. The same study indicated that the sales of etoricoxib accounts for nearly 28 percent in Singapore. According to a report published by Allied Market Research titled “World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 – 2020,” the aforementioned market would see a CAGR of 5.8 percent during the forecast period 2014 to 2020.

Fiber Optic Market Observes Great Momentum in 2015

Today, whether a business owner is considering, installing a new fiber optic network or repairing an existing system, fiber optic connectors are a must. Furthermore, the rapidly growing demand for high bandwidth, among end-users has been majorly responsible for the expansion of the fiber optic connector sector. Surprisingly, over the past four to five years the fiber optic connector segment has widened the investment pockets with more companies rolling out funds, collaborating and considering mergers and acquisitions. Likewise, the major surprise came in June 2015 with “Furukuwa Electric,” making known its intention to start a new fiber- optic cable manufacturing unit in Morocco. Initially the aforementioned company would aim at supplying fiber optic cables to several telecom giants in countries including Europe and Africa reveals an article on “Morocco  World News “. The same source explained that the company also has plans to manufacture connectors in the near future.

 According to another report “Optical Fiber Corporation” popular for manufacturing fiber optic, copper cabling and copper connectors among others has finally cleared all doubts over its share repurchase intent. Commenting on the plan, The President and CEO on July 14, 2015, Neil Wilkin at Optical Cable Corporation said "The repurchase plan announced today underscores the Board of Directors' continuing confidence and belief in OCC's long-term prospects.  OCC's strong balance sheet and cash flow from operating activities give us the flexibility to invest in our business and institute this repurchase plan." In addition, to the growing investment pocket joint ventures too are encouraging structured partnership in the fiber optic connector segment. On similar grounds, “Valdor Technology International Inc.” entered into a joint venture with “Inteligencia e Infraestructura En America S.A.” to become a prominent market player in Mexico in August 2014 .

Moreover, Valdor and Inteligencia has agreed upon offering 50 percent of the total investment and share the gains equally. The joint venture would initially start supplying and aim at manufacturing a wide range of integrated optical items, optical connectors and patch panels among several others. Eyeing the future prospects of the optical fiber connector market in coming four to five years Allied Market Research has published a report titled “World Fiber Optic Connectors - Market Opportunities and Forecasts, 2014 – 2020.” According to the report the fiber optic connector segment worldwide would rapidly grow across regions such as LAMEA, North America, Asia –Pacific and Europe. 

Global Colocation Industry To Be Dominated By Retail And Wholesale Hosting Solution

The growing demand for Cloud technology drives the world colocation market today. According to an article published in the “Data Center Knowledge “the colocation segment is undergoing consolidation with various active participants considering collaboration, acquisitions and mergers. Furthermore, a study conducted by IMS Research firm, the aforesaid market in North America was valued at $ 6.5 billion in 2012. In addition IMS’s research indicates that the colocation industry would increase by $10 billion by the end of 2017. This growth would be visible in both retail as well as wholesale colocation data center services, and shows a strong foothold in the demand for multi-tenant space. In a discussion held at the “Data Center World “, the associate director at IMS Associate, Jason dePreaux explained that the wholesale colocation represented $2 billion of the total in 2012. Jason added that the retailcolocation accounted for the remaining $4.5 billion the same year. “Fierce Telecom” reveals that global retail colocation proceeds are growing annually 10percent, with China contributing over double the global average. Apart from this countries such as United Kingdom, Netherlands and Germany expanding over average rates.

Likewise, there are nearly 20 nations and each contributes to approximately $100 million each year in retail colocation figures. Besides this, the proceeds generated by the wholesale colocation, which contributes to just a quarter size compared to retail colocation, are also expanding at a greater pace. In an article published on “Datacenter Dynamics “ , John Dinsdale, the chief analyst and research director with the Synergy Research Group said "Despite the strong trend in companies shifting IT workloads from their own data center infrastructure to cloud services, growth in colocation remains robust in most countries.”  John commented "With over 60% ofcolocation spend coming from various types of service provider, the colocation market is reasonably well insulated against major shifts in IT strategy within the enterprise sector." According to a report published by Allied Market Research titled “World Colocation - Market Opportunities and Forecasts, 2014 – 2020, “the global colocation segment is expanding in regions including LAMEA, North America, Europe and Asia –Pacific. The report uncovers that the colocation industry worldwide would see a CAGR of 12.4 percent during the forecast period of 2012 to 2020. 

Growing Concerns Over Diabetes Drives The Continuous Glucose Monitoring Market

Today, Diabetes is a common, serious, expensive, growing and probably an inescapable public health issue. According to a publication by the “National Center for Chronic Disease Prevention and Health Promotion”, around 135 million people in 1995 were diagnosed with diabetes and the number would grow up to 300 million by the end of 2025. Furthermore, many risk factors are associated with the aforesaid disease such as dietary problems, obesity, insulin resistance and more health issues. Several health officials believe diabetes can be avoided in the high -risk category, but people are yet to observe the results of several clinical trials that are pending.

Meanwhile many glucose monitoring systems, the most affordably acceptable technology are undergoing a face lift worldwide. These medical devices can lower the burden of complications by early detection of diabetes. Device manufacturers are now ready to catch -up with an accurate data for continuous glucose monitoring through their inventions. In 2015, under the sensors category Dexcom became one of its kind to provide continuous glucose monitoring data from the “Apple Watch”. Product's G4 PLATINUM system needs users to just pierce underneath their skin. Users then attaches a “Bluetooth LTE” receiver that sends data to an “Apple Watch ". Some more popular product choices in the sensors category today includes CIGMS by GlySure Limited; Brian Otis's brainchild smart contact lens and Flash Glucose Monitoring System from Abbott.

Similarly, government bodies too are giving a nod to severalmonitoring technologies for people with diabetes. In one such example in January 2015 FDA had approved Dexcom mobile application for constant glucose monitoring. In a similar incident FDA in US had backed the use of “Nova StatStrip Glucose Hospital Meter System" for severely ill patient who were hospitalized. This was the first time a BGMS was approved by FDA for such patients. An article published in the “Diabetes Daily" indicates that the global sales of test-strip as well as glucose meter supplies reach over 10 million dollars each year. According to a report titled " Continuous Glucose Monitoring Market " published by Allied Market Research the CGM market is valued at $568.5 million is 2020. The report reveals that the aforementioned market would see a CAGR of 14.8 percent during the forecast period of 2012 to 2020.